Moreover, Kai et al. demonstrated that saxagliptin alleviates the contents of inflammatory cytokine including TNF-α, IL-6, IL-1β, and MCP-1 in ALI treatment [21]. This evidence concerns the gene IL6 and acute respiratory distress syndrome.